Clinical targeting of HIV capsid protein with a long-acting small molecule

Clinical targeting of HIV capsid protein with a long-acting small molecule

Nature, Published online: 01 July 2020; doi:10.1038/s41586-020-2443-1

The small molecule GS-6207, which disrupts the function of the HIV capsid protein, shows potential as a long-acting therapeutic agent for the treatment and prevention of HIV infection.
Source: Nature